Selbyville, Delaware, Dec. 16, 2024 (GLOBE NEWSWIRE) --
Preimplantation genetic testing market size was valued at USD 780.8 million in 2023, is projected to grow at a CAGR of 9.4% from 2024 to 2032. This growth is driven by a rising awareness of reproductive health and a growing demand for genetic disorder screening in newborns.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/12034
PGT provides families with a proactive option to detect genetic abnormalities in embryos before implantation, helping prevent hereditary conditions and enhancing overall reproductive outcomes.
The preimplantation genetic testing market is segmented by product and service categories. The product segment, which includes essential reagents, sequencing kits, and testing consumables used in IVF procedures, led the market in 2023 and is expected to grow at a CAGR of 9.3% during 2024-2032. The increasing rate of genetic disorders, coupled with the expanding adoption of IVF, has heightened the demand for these kits and consumables. Recent advancements in genetic technologies like next-generation sequencing (NGS) have driven demand and created more precise and efficient testing kits. The consumables’ recurring nature also ensures a stable revenue stream, underscoring the profitability of this segment.
Technologically, the preimplantation genetic testing market includes NGS, fluorescent in-situ hybridization (FISH), polymerase chain reaction (PCR), array-based methods, and more. NGS holds the largest market share at 42% in 2023 due to its speed, accuracy, and ability to detect a wide range of genetic abnormalities in one test. This technology can sequence multiple embryos simultaneously, reducing costs and increasing efficiency for fertility clinics and researchers. As the demand for precise screening intensifies, the adoption of NGS in PGT continues to rise, establishing it as a leader in reproductive genetic technology.
Regionally, the U.S. dominated the North American preimplantation genetic testing market in 2023, accounting for USD 312.2 million, and is expected to maintain this lead through the forecast period. The country’s extensive adoption of advanced reproductive technologies and a strong awareness of genetic screening contribute to this dominance. Moreover, top fertility clinics and cutting-edge PGT providers further solidify the U.S. position in the North American market.
The preimplantation genetic testing market is set for steady progression due to the increasing focus on reproductive health and genetic screening advancements. With product innovations and the expanding utilization of high-precision genetic technologies, the PGT market remains poised to meet the needs of a growing demographic seeking enhanced reproductive options.
Request for Report Customization @ https://www.gminsights.com/roc/12034
Major players in preimplantation genetic testing market include Agilent Technologies, Fulgent Genetics, Genea BIOMEDX, Illumina, Medicover Genetics, Natera, Revvity, RGI, Takara Bio, Thermo Fisher Scientific, Varinos, Virtus Health, and Vitrolife Group (Igenomix) among others.
Partial Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of genetic diseases
3.2.1.2 Increasing prevalence of infertility rate
3.2.1.3 Growing advancements in PGT technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of genetic testing
3.2.2.2 Technical challenges in PGT methods
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Browse more biotechnology R&D industry reports @ https://www.gminsights.com/industry-reports/biotechnology-randd/82
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
